We are proud to announce the signing of a Memorandum of Understanding (MOU) with ChemLex at the grand opening of their global HQ, graced by Minister of State, Ministry of Foreign Affairs & Ministry of Trade and Industry Ms Gan Siow Huang. EDDC and ChemLex aim to further leverage our scientific expertise and their world-class AI and automation-driven chemical synthesis capabilities to accelerate small molecule drug discovery and development. This collaboration expands our ongoing partnership and reflects our shared commitment to harnessing cutting-edge science and technology to push the boundaries of translational research innovation. The signing with ChemLex CEO Dr Sean Lin was witnessed by A*STAR CE Mr Beh Kian Teik, EDB Managing Director Mr Jermaine Loy, and LYFE Capital Founder and Partner James Zhao.
(from left to right: Yinghui Kuang, Partner, Granite Asia | Saif Khan, Head of Chemical Engineering, NUS | Cindy Khoo, Managing Director, Enterprise Singapore | James Zhao, Founder and Partner, LYFE Capital | Jermaine Loy, Managing Director, EDB | Damian O’Connell, CEO, EDDC | Sean Lin, CEO and Founder, ChemLex | Gan Siow Huang, Minister of State, Ministry of Foreign Affairs & Ministry of Trade and Industry | Beh Kian Teik, CEO, A*STAR | Sharon Chan, Vice President, JLABS Asia, Pacific Johnson & Johnson | Shawn Hoon, CSO, Automera Therapeutics | Lew Chuen Hong, Partner, Granite Asia)
“We first met ChemLex in 2023, and since then we’ve seen the company grow from a promising startup to a global innovator in AI and automation-driven chemical synthesis. As ChemLex’s first Singapore partner, we are thrilled to expand our collaboration through the MOU. This partnership reinforces our shared vision of accelerating drug discovery and development through cutting-edge technology, ultimately bringing safer, more effective therapies to patients faster. By combining EDDC’s drug development expertise with ChemLex’s automation and AI capabilities, we aim to shorten timelines, reduce costs, and deliver innovative treatments that improve lives in Singapore and globally,” says EDDC CEO Prof Damian O’Connell.
See here for ChemLex’s full press release: https://www.prnewswire.com/apac/news–releases/ai-for-science-startup-chemlex-raises-usd-45m-launching-self-driving-lab-for-drug-discovery-in-singapore-302634777.html